Data from a study comparing the efficacy of anetumab ravtansine, a monoclonal antibody conjugate, against vinorelbine showed no improvement in progression-free survival. The results of…
Data from a study comparing the efficacy of anetumab ravtansine, a monoclonal antibody conjugate, against vinorelbine showed no improvement in progression-free survival. The results of…